Stockscreener 앱 받기
23.39
3.47%
-0.84
시간 외 거래:
23.26
-0.13
-0.56%
전일 마감가:
$24.23
열려 있는:
$24.09
하루 거래량:
6.44M
Relative Volume:
1.06
시가총액:
$11.68B
수익:
$4.89B
순이익/손실:
$-242.00M
주가수익비율:
-47.83
EPS:
-0.489
순현금흐름:
$315.00M
1주 성능:
+2.27%
1개월 성능:
+17.77%
6개월 성능:
+5.93%
1년 성능:
+71.86%
1일 변동 폭
$23.15
$24.42
1주일 범위
$22.76
$25.07
52주 변동 폭
$13.15
$27.72
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
23.39 | 12.13B | 4.89B | -242.00M | 315.00M | -0.489 |
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.87 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.56 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.26 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
551.47 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | 업그레이드 | Argus | Hold → Buy |
| 2025-10-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-07-17 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Elanco CEO: Screwworm Easier To Manage Than Contain - marketscreener.com
9 New 4-Star Stocks This Week - Morningstar
Elanco (ELAN) Introduces TruCan Ultra Lyme-L4 Vaccine for Dogs - GuruFocus
Elanco receives USDA approval for canine combination vaccine By Investing.com - Investing.com Canada
New low-volume dog vaccine targets Lyme and leptospirosis in a single shot - Stock Titan
Elanco Animal Health Incorporated $ELAN Position Reduced by Black Creek Investment Management Inc. - MarketBeat
Private Management Group Inc. Reduces Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Q1 earnings call highlights - MSN
Brandes Investment Partners LP Has $95.09 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc (ELAN) Shares Surge 3.5% -- What GF Sco - GuruFocus
Norges Bank Makes New $32.42 Million Investment in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Sold by Bank of New York Mellon Corp - MarketBeat
Elanco Animal Health (ELAN) Stock Analysis: A 26% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Clearbridge Investments LLC Has $128.37 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Harvest Fund Management Co. Ltd Has $366,000 Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
TD Asset Management Inc Purchases 516,628 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Jim Cramer Recommends Elanco Over Zoetis - Insider Monkey
Is Elanco’s Big Rally Still Worth Watching After Its Sharp Climb? - Kalkine Media
Earnings call transcript: Elanco Animal Health Q1 2026 surpasses expectations with strong growth - Investing.com
Is It Too Late To Consider Elanco Animal Health (ELAN) After Its Strong 1 Year Rally? - Yahoo Finance
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm - CSRwire
Elanco offers treatments for New World screwworm in U.S. livestock By Investing.com - Investing.com Canada
Elanco Animal HealthOffers Treatment Options For Livestock And Pets Against New World Screwworm - TradingView
Elanco Animal Health Incorporated $ELAN Shares Bought by Bowen Hanes & Co. Inc. - MarketBeat
Elanco Animal Health Commits to Supporting U.S. Livestock Produc - GuruFocus
Elanco Animal Health Inc (ELAN) Stock Up 4.0% but GF Value Says Overvalued -- GF Score: 66/100 - GuruFocus
Survey: Pet owners maintain health spending despite rising costs - PetfoodIndustry
Jim Cramer Says He Feels 'Something Not Well' At Zoetis, Names A Rival As His Pick - Benzinga
U.S. pet owners cut dining out before pet care, Elanco finds - Stock Titan
Peak Retirement Planning Inc. Acquires Shares of 121,770 Elanco Animal Health Incorporated $ELAN - MarketBeat
Geode Capital Management LLC Buys 640,098 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
BNP Paribas Financial Markets Purchases 2,193,391 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco (ELAN) CFO granted new deferred stock units under compensation plan - Stock Titan
Elanco (ELAN) officer Rajeev Modi receives deferred stock unit grant - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons granted new deferred stock units - Stock Titan
Elanco (ELAN) Q1 2026 Earnings Transcript - AOL.com
Legal & General Group Plc Has $17.68 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
A Look At Elanco (ELAN) Valuation After Early Befrena Launch And Renewed Investor Optimism - Yahoo Finance
Elanco (ELAN) Is Up 9.8% After Launching Befrena, Its Second USDA-Approved Pet Biologic - Yahoo Finance
EBIT per share of Elanco Animal Health, Inc. – LS:A2N6BH - TradingView
Barclays Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Ribbon cut on $200 million Elanco animal health campus - MSN
Jupiter Asset Management Ltd. Trims Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Shareholders Back Board, Auditor and Executive Pay - The Globe and Mail
Jackson Creek Investment Advisors LLC Buys Shares of 65,370 Elanco Animal Health Incorporated $ELAN - MarketBeat
Royce & Associates LP Sells 107,638 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Northwestern Mutual Wealth Management Co. Grows Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health 2026 Shareholder Meeting Results: Board Elections and Executive Compensation Vote - Minichart
A Look at Elanco Animal Health Inc (ELAN) After 3.8% Gain -- GF Value $15.53 vs Price $23.69 - GuruFocus
Elanco (NYSE: ELAN) investors reelect board and ratify 2026 auditor - Stock Titan
Monumental Public-Private Initiative Forms to Permanently Close America’s Protein Gap - CSRwire
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.13%
0.95%
자본화:
|
볼륨(24시간):